<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IP Patent News &#187; Medical Patent News</title>
	<atom:link href="http://www.ip-patent-news.com/tag/medical-patent-news/feed" rel="self" type="application/rss+xml" />
	<link>http://www.ip-patent-news.com</link>
	<description>24/7 Technology,Internet,Bio Patent and Intellectual Property News &#38; Information Service</description>
	<lastBuildDate>Fri, 10 Sep 2010 04:56:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Edimer Pharmaceuticals, CMC Biologics enter contract to develop EDI200 recombinant protein</title>
		<link>http://www.news-medical.net/news/20100910/Edimer-Pharmaceuticals-CMC-Biologics-enter-contract-to-develop-EDI200-recombinant-protein.aspx</link>
		<comments>http://www.ip-patent-news.com/edimer-pharmaceuticals-cmc-biologics-enter-contract-to-develop-edi200-recombinant-protein#comments</comments>
		<pubDate>Fri, 10 Sep 2010 04:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Dysplasia]]></category>
		<category><![CDATA[Ectodermal]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Xlhed]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/edimer-pharmaceuticals-cmc-biologics-enter-contract-to-develop-edi200-recombinant-protein</guid>
		<description><![CDATA[[Story ID: 3611] Edimer Pharmaceuticals and CMC Biologics today announce the execution of a manufacturing contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/edimer-pharmaceuticals-cmc-biologics-enter-contract-to-develop-edi200-recombinant-protein">3611</a>]</small>
<p>Edimer Pharmaceuticals and CMC Biologics today announce the execution of a manufacturing contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/edimer-pharmaceuticals-cmc-biologics-enter-contract-to-develop-edi200-recombinant-protein/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioSpace joins with Delaware BioScience to launch online career center for life science markets</title>
		<link>http://www.news-medical.net/news/20100909/BioSpace-joins-with-Delaware-BioScience-to-launch-online-career-center-for-life-science-markets.aspx</link>
		<comments>http://www.ip-patent-news.com/biospace-joins-with-delaware-bioscience-to-launch-online-career-center-for-life-science-markets#comments</comments>
		<pubDate>Thu, 09 Sep 2010 04:56:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Life]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Science]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/biospace-joins-with-delaware-bioscience-to-launch-online-career-center-for-life-science-markets</guid>
		<description><![CDATA[[Story ID: 3605] BioSpace has partnered with the Delaware BioScience Association to launch an online career center for life science markets including pharmaceuticals and biotechnology.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/biospace-joins-with-delaware-bioscience-to-launch-online-career-center-for-life-science-markets">3605</a>]</small>
<p>BioSpace has partnered with the Delaware BioScience Association to launch an online career center for life science markets including pharmaceuticals and biotechnology.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/biospace-joins-with-delaware-bioscience-to-launch-online-career-center-for-life-science-markets/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Static stretching leads to decreased running performance</title>
		<link>http://www.news-medical.net/news/20100908/Static-stretching-leads-to-decreased-running-performance.aspx</link>
		<comments>http://www.ip-patent-news.com/static-stretching-leads-to-decreased-running-performance#comments</comments>
		<pubDate>Wed, 08 Sep 2010 04:56:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Conditioning]]></category>
		<category><![CDATA[Journal]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Strength]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/static-stretching-leads-to-decreased-running-performance</guid>
		<description><![CDATA[[Story ID: 3594] Distance runners who stretch before running may not be able to run as far&#8217;]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/static-stretching-leads-to-decreased-running-performance">3594</a>]</small>
<p>Distance runners who stretch before running may not be able to run as far&#8217;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/static-stretching-leads-to-decreased-running-performance/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Combined treatment may benefit early-stage schizophrenia patients: Report</title>
		<link>http://www.news-medical.net/news/20100907/Combined-treatment-may-benefit-early-stage-schizophrenia-patients-Report.aspx</link>
		<comments>http://www.ip-patent-news.com/combined-treatment-may-benefit-early-stage-schizophrenia-patients-report#comments</comments>
		<pubDate>Tue, 07 Sep 2010 04:53:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Medication]]></category>
		<category><![CDATA[Report]]></category>
		<category><![CDATA[September]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/combined-treatment-may-benefit-early-stage-schizophrenia-patients-report</guid>
		<description><![CDATA[[Story ID: 3583] Patients with early stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse and may have improved insight, quality of life and social functioning than those taking medication alone, according to a report in the September issue of Archives of General Psychiatry, [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/combined-treatment-may-benefit-early-stage-schizophrenia-patients-report">3583</a>]</small>
<p>Patients with early stage schizophrenia who receive a combination of medication and a psychosocial intervention appear less likely to discontinue treatment or relapse and may have improved insight, quality of life and social functioning than those taking medication alone, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/combined-treatment-may-benefit-early-stage-schizophrenia-patients-report/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unpredictable food poisoning</title>
		<link>http://www.news-medical.net/news/20100906/Unpredictable-food-poisoning.aspx</link>
		<comments>http://www.ip-patent-news.com/unpredictable-food-poisoning#comments</comments>
		<pubDate>Mon, 06 Sep 2010 04:41:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Dont]]></category>
		<category><![CDATA[Food]]></category>
		<category><![CDATA[Ill]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/unpredictable-food-poisoning</guid>
		<description><![CDATA[[Story ID: 3576] While we are often exposed to bacteria in our food which could cause food poisoning, we don&#8217;t always become ill &#8211; why should this be so?]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/unpredictable-food-poisoning">3576</a>]</small>
<p>While we are often exposed to bacteria in our food which could cause food poisoning, we don&#8217;t always become ill &#8211; why should this be so?</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/unpredictable-food-poisoning/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TimeTemps shelf-life indicator for food will help Norwegian retailers reduce waste</title>
		<link>http://www.news-medical.net/news/20100904/TimeTemps-shelf-life-indicator-for-food-will-help-Norwegian-retailers-reduce-waste.aspx</link>
		<comments>http://www.ip-patent-news.com/timetemps-shelf-life-indicator-for-food-will-help-norwegian-retailers-reduce-waste#comments</comments>
		<pubDate>Sat, 04 Sep 2010 09:45:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Food]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Norway]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/timetemps-shelf-life-indicator-for-food-will-help-norwegian-retailers-reduce-waste</guid>
		<description><![CDATA[[Story ID: 3567] Norwegian food retailers discard over 50,000 tonnes of food annually &#8211; much of it of perfectly good quality. New technology from Norway could substantially reduce this wastefulness.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/timetemps-shelf-life-indicator-for-food-will-help-norwegian-retailers-reduce-waste">3567</a>]</small>
<p>Norwegian food retailers discard over 50,000 tonnes of food annually &#8211; much of it of perfectly good quality. New technology from Norway could substantially reduce this wastefulness.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/timetemps-shelf-life-indicator-for-food-will-help-norwegian-retailers-reduce-waste/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study suggest PET/CT scanning may offer effective breast cancer detection</title>
		<link>http://www.news-medical.net/news/20100904/Study-suggest-PETCT-scanning-may-offer-effective-breast-cancer-detection.aspx</link>
		<comments>http://www.ip-patent-news.com/study-suggest-petct-scanning-may-offer-effective-breast-cancer-detection#comments</comments>
		<pubDate>Sat, 04 Sep 2010 04:45:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Breast]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/study-suggest-petct-scanning-may-offer-effective-breast-cancer-detection</guid>
		<description><![CDATA[[Story ID: 3559] About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/study-suggest-petct-scanning-may-offer-effective-breast-cancer-detection">3559</a>]</small>
<p>About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be more effective at detecting breast tumors that have reached nearby bones.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/study-suggest-petct-scanning-may-offer-effective-breast-cancer-detection/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Researchers receive BioBank DNA samples to unveil psoriasis genetics</title>
		<link>http://www.news-medical.net/news/20100903/Researchers-receive-BioBank-DNA-samples-to-unveil-psoriasis-genetics.aspx</link>
		<comments>http://www.ip-patent-news.com/researchers-receive-biobank-dna-samples-to-unveil-psoriasis-genetics#comments</comments>
		<pubDate>Fri, 03 Sep 2010 04:57:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Psoriasis]]></category>
		<category><![CDATA[Psoriatic]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/researchers-receive-biobank-dna-samples-to-unveil-psoriasis-genetics</guid>
		<description><![CDATA[[Story ID: 3553] Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the release of the first National Psoriasis Victor Henschel BioBank DNA samples for use in research at the University of Michigan Health System; research that hopes to uncover the unknowns about the genetics of psoriasis [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/researchers-receive-biobank-dna-samples-to-unveil-psoriasis-genetics">3553</a>]</small>
<p>Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the release of the first National Psoriasis Victor Henschel BioBank DNA samples for use in research at the University of Michigan Health System; research that hopes to uncover the unknowns about the genetics of psoriasis and psoriatic arthritis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/researchers-receive-biobank-dna-samples-to-unveil-psoriasis-genetics/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>USFDA grants Sun Pharma subsidiary approval for generic Strattera capsules ANDA</title>
		<link>http://www.news-medical.net/news/20100902/USFDA-grants-Sun-Pharma-subsidiary-approval-for-generic-Strattera-capsules-ANDA.aspx</link>
		<comments>http://www.ip-patent-news.com/usfda-grants-sun-pharma-subsidiary-approval-for-generic-strattera-capsules-anda#comments</comments>
		<pubDate>Thu, 02 Sep 2010 04:56:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Anda]]></category>
		<category><![CDATA[Generic]]></category>
		<category><![CDATA[Market]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/usfda-grants-sun-pharma-subsidiary-approval-for-generic-strattera-capsules-anda</guid>
		<description><![CDATA[[Story ID: 3547] Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/usfda-grants-sun-pharma-subsidiary-approval-for-generic-strattera-capsules-anda">3547</a>]</small>
<p>Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/usfda-grants-sun-pharma-subsidiary-approval-for-generic-strattera-capsules-anda/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tooth brush in a teenagers stomach</title>
		<link>http://www.news-medical.net/news/20100831/Tooth-brush-in-a-teenagere28099s-stomach.aspx</link>
		<comments>http://www.ip-patent-news.com/tooth-brush-in-a-teenagers-stomach#comments</comments>
		<pubDate>Tue, 31 Aug 2010 20:22:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Toothbrush]]></category>
		<category><![CDATA[Zealand]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/tooth-brush-in-a-teenagers-stomach</guid>
		<description><![CDATA[[Story ID: 3539] A 15-year-old girl in New Zealand came to the emergency department at an Auckland hospital after accidentally swallowing her 19-centimetre toothbrush. The case study was published in the New Zealand Medical Journal.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/tooth-brush-in-a-teenagers-stomach">3539</a>]</small>
<p>A 15-year-old girl in New Zealand came to the emergency department at an Auckland hospital after accidentally swallowing her 19-centimetre toothbrush. The case study was published in the New Zealand Medical Journal.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/tooth-brush-in-a-teenagers-stomach/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
